{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:49:21Z","timestamp":1791200961928,"version":"4.2.0"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023561","name":"Government of Spain Ministry of Universities","doi-asserted-by":"publisher","award":["PRE2022-101521"],"award-info":[{"award-number":["PRE2022-101521"]}],"id":[{"id":"10.13039\/501100023561","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023561","name":"Government of Spain Ministry of Universities","doi-asserted-by":"publisher","award":["PID2021-122714OB-I00"],"award-info":[{"award-number":["PID2021-122714OB-I00"]}],"id":[{"id":"10.13039\/501100023561","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009042","name":"University of Seville","doi-asserted-by":"publisher","award":["US-1263053"],"award-info":[{"award-number":["US-1263053"]}],"id":[{"id":"10.13039\/100009042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["MICIU\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["MICIU\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PRE2022-101521"],"award-info":[{"award-number":["PRE2022-101521"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PID2021-122714OB-I00"],"award-info":[{"award-number":["PID2021-122714OB-I00"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.colsurfb.2025.115057","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T16:03:42Z","timestamp":1755619422000},"page":"115057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P2","title":["Cannabinoid effective targeting of atherosclerotic plaques   by optimized-PLGA nanoparticles"],"prefix":"10.1016","volume":"256","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5534-6955","authenticated-orcid":false,"given":"L.","family":"Mart\u00edn-Navarro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7231-9537","authenticated-orcid":false,"given":"M.D.","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3525-8488","authenticated-orcid":false,"given":"J.","family":"\u00c1lvarez-Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9943-405X","authenticated-orcid":false,"given":"Carmen","family":"Claro-Cala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1447-6125","authenticated-orcid":false,"given":"L.","family":"Mart\u00edn-Banderas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2025.115057_bib1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.colsurfb.2025.115057_bib2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12471-017-0959-2","article-title":"Pathophysiology and treatment of atherosclerosis: current view and future perspective on lipoprotein modification treatment","volume":"25","author":"Bergheanu","year":"2017","journal-title":"Neth. Hear. J."},{"key":"10.1016\/j.colsurfb.2025.115057_bib3","article-title":"Targeting inflammation in atherosclerosis \u2014 from experimental insights to the clinic","volume":"0123456789","author":"Soehnlein","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.colsurfb.2025.115057_bib4","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the european atherosclerosis society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.colsurfb.2025.115057_bib5","first-page":"139","article-title":"Endothelial cell dysfunction and the pathobiology of atherosclerosis","volume":"176","author":"Michael A","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.colsurfb.2025.115057_bib6","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41419-024-07166-8","article-title":"Inflammation in atherosclerosis: pathophysiology and mechanisms","volume":"15","author":"Ajoolabady","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.colsurfb.2025.115057_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2022.107090","article-title":"Late phase endothelial cell inflammation is characterized by interferon response genes and driven by JAK\/STAT, not NF\u03baB","volume":"146","author":"Valenzuela","year":"2022","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.colsurfb.2025.115057_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.6061\/clinics\/2018\/e203","article-title":"Relationship between circulating VCAM-1, ICAM-1, E-selectin and MMP9 and the extent of coronary lesions","volume":"73","author":"Santos","year":"2018","journal-title":"Clinics"},{"key":"10.1016\/j.colsurfb.2025.115057_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2022.825459","article-title":"Blocking VCAM-1 prevents angiotensin II-Induced hypertension and vascular remodeling in mice","volume":"13","author":"Yin","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.colsurfb.2025.115057_bib10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/14728222.2023.2187778","article-title":"Targeting VCAM-1: a therapeutic opportunity for vascular damage","volume":"27","author":"Troncoso","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.colsurfb.2025.115057_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.118.009099","article-title":"Cannabinoids, the heart of the matter","volume":"7","author":"Alfulaij","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.colsurfb.2025.115057_bib12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/clc.21962","article-title":"Cannabinoids and atherosclerotic coronary heart disease","volume":"35","author":"Singla","year":"2012","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.colsurfb.2025.115057_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrcardio.2017.130","article-title":"Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly","volume":"15","author":"Pacher","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.colsurfb.2025.115057_bib14","doi-asserted-by":"crossref","first-page":"9102","DOI":"10.1021\/acs.jafc.0c07251","article-title":"Cannabis seed oil alleviates experimental atherosclerosis by ameliorating vascular inflammation in Apolipoprotein-E-Deficient mice","volume":"69","author":"Huang","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.colsurfb.2025.115057_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4587024","article-title":"G. Garci\u00e1-Rivas, Therapeutic applications of cannabinoids in cardiomyopathy and heart failure","volume":"2020","author":"Garza-Cervantes","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.colsurfb.2025.115057_bib16","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/nature03389","article-title":"Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice","volume":"434","author":"Steffens","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.colsurfb.2025.115057_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29143381","article-title":"The impact of the CB2 cannabinoid receptor in inflammatory diseases: an update","volume":"29","author":"Rakotoarivelo","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.colsurfb.2025.115057_bib18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/ACO.0000000000000616","article-title":"An overview of the cannabinoid type 2 receptor system and its therapeutic potential","volume":"31","author":"Bie","year":"2018","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"10.1016\/j.colsurfb.2025.115057_bib19","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1021\/acsptsci.9b00049","article-title":"Cannabinoid receptor 2 (CB2) signals via G-alpha-s and induces IL-6 and IL-10 cytokine secretion in human primary leukocytes","volume":"2","author":"Saroz","year":"2019","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.colsurfb.2025.115057_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2022.908198","article-title":"Medical cannabis activity against inflammation: active compounds and modes of action","volume":"13","author":"Anil","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.colsurfb.2025.115057_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174398","article-title":"Pharmacological potential of JWH133, a cannabinoid type 2 receptor agonist in neurodegenerative, neurodevelopmental and neuropsychiatric diseases","volume":"909","author":"Hashiesh","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.colsurfb.2025.115057_bib22","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.yjmcc.2011.08.008","article-title":"Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo","volume":"51","author":"Hoyer","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.colsurfb.2025.115057_bib23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3390\/immuno1030020","article-title":"Cannabinoid Type-2 receptor agonist, JWH133 May be a possible candidate for targeting infection, inflammation, and immunity in COVID-19","volume":"1","author":"Jha","year":"2021","journal-title":"Immuno"},{"key":"10.1016\/j.colsurfb.2025.115057_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118424","article-title":"CB2R agonist JWH-133 attenuates chronic inflammation by restraining M1 macrophage polarization via Nrf2\/HO-1 pathway in diet-induced obese mice","volume":"260","author":"Wu","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.colsurfb.2025.115057_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.colsurfb.2025.115057_bib26","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1177\/1535370216640940","article-title":"Targeting and therapeutic peptides in nanomedicine for atherosclerosis","volume":"241","author":"Chung","year":"2016","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.colsurfb.2025.115057_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/adhm.202000336","article-title":"Nanomedicine approaches for advanced diagnosis and treatment of atherosclerosis and related ischemic diseases","volume":"9","author":"Hu","year":"2020","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.colsurfb.2025.115057_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.15171\/bi.2018.08","article-title":"Combating atherosclerosis with targeted nanomedicines: recent advances and future prospective","volume":"8","author":"Nakhlband","year":"2018","journal-title":"BioImpacts"},{"key":"10.1016\/j.colsurfb.2025.115057_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics14122728","article-title":"PLGA-Based nanomedicine: history of advancement and development in clinical applications of multiple diseases","volume":"14","author":"Alsaab","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2025.115057_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e38165","article-title":"The drug release of PLGA-based nanoparticles and their application in treatment of gastrointestinal cancers","volume":"10","author":"Sun","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.colsurfb.2025.115057_bib31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2025.115057_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fbioe.2022.882363","article-title":"Understanding the role and impact of poly (Ethylene Glycol) (PEG) on nanoparticle formulation: implications for COVID-19 vaccines","volume":"10","author":"Pad\u00edn-Gonz\u00e1lez","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.colsurfb.2025.115057_bib33","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/j.nano.2017.07.010","article-title":"Single oral dose of cannabinoid derivate loaded PLGA nanocarriers relieves neuropathic pain for eleven days","volume":"13","author":"Berrocoso","year":"2017","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.colsurfb.2025.115057_bib34","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/737526","article-title":"Development and validation of an RP-HPLC method for CB13 evaluation in several PLGA nanoparticle systems","volume":"2012","author":"\u00c1lvarez-Fuentes","year":"2012","journal-title":"Sci. World J."},{"key":"10.1016\/j.colsurfb.2025.115057_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121524","article-title":"Potential use for chronic pain: poly(ethylene glycol)-poly(lactic-co-glycolic acid) nanoparticles enhance the effects of Cannabis-Based terpenes on calcium influx in TRPV1-Expressing cells","volume":"616","author":"El-Hammadi","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2025.115057_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.indcrop.2021.113345","article-title":"Development of enhanced drug delivery vehicles for three cannabis-based terpenes using poly(lactic-co-glycolic acid) based nanoparticles","volume":"164","author":"El-Hammadi","year":"2021","journal-title":"Ind. Crops Prod."},{"key":"10.1016\/j.colsurfb.2025.115057_bib37","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1166\/jbn.2014.1806","article-title":"Enhanced cellular uptake and biodistribution of a synthetic cannabinoid loaded in surface-modified poly(lactic-co-glycolic acid) nanoparticles","volume":"10","author":"Dur\u00e1n-Lobato","year":"2014","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.colsurfb.2025.115057_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-05301-z","article-title":"Receptor-targeted nanoparticles modulate cannabinoid anticancer activity through delayed cell internalization","volume":"12","author":"Dur\u00e1n-Lobato","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.colsurfb.2025.115057_bib39","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/j.nano.2017.07.010","article-title":"Single oral dose of cannabinoid derivate loaded PLGA nanocarriers relieves neuropathic pain for eleven days","volume":"13","author":"Berrocoso","year":"2017","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.colsurfb.2025.115057_bib40","article-title":"Peptide-based nanosystems for vascular cell adhesion molecule-1 targeting: a real opportunity for therapeutic and diagnostic agents in inflammation associated disorders","volume":"55","author":"Ailuno","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.colsurfb.2025.115057_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules24193499","article-title":"Biodistribution of nanostructured lipid carriers in mice atherosclerotic model","volume":"24","author":"Devel","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.colsurfb.2025.115057_bib42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41401-020-0436-0","article-title":"Application of targeted therapy strategies with nanomedicine delivery for atherosclerosis","volume":"42","author":"Ou","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.colsurfb.2025.115057_bib43","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.nano.2018.12.015","article-title":"Unambiguous detection of atherosclerosis using bioorthogonal nanomaterials","volume":"17","author":"Pellico","year":"2019","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.colsurfb.2025.115057_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0083805","article-title":"Characterization of VCAM-1-binding peptide-functionalized quantum dots for molecular imaging of inflamed endothelium","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.colsurfb.2025.115057_bib45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejpb.2014.11.016","article-title":"VCAM-1 directed target-sensitive liposomes carrying CCR2 antagonists bind to activated endothelium and reduce adhesion and transmigration of monocytes","volume":"89","author":"Calin","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2025.115057_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11080391","article-title":"Functional role of VCAM-1 targeted flavonoid-loaded lipid nanoemulsions in reducing endothelium inflammation","volume":"11","author":"Fuior","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2025.115057_bib47","article-title":"Peptide-based nanosystems for vascular cell adhesion molecule-1 targeting: a real opportunity for therapeutic and diagnostic agents in inflammation associated disorders","volume":"55","author":"Ailuno","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.colsurfb.2025.115057_bib48","first-page":"1","article-title":"Vcam-1 target in non-invasive imaging for the detection of atherosclerotic plaques","volume":"9","author":"Thayse","year":"2020","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.colsurfb.2025.115057_bib49","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.colsurfb.2014.09.002","article-title":"Engineering of \u03b49-tetrahydrocannabinol delivery systems based on surface modified-PLGA nanoplatforms","volume":"123","author":"Mart\u00edn-Banderas","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2025.115057_bib50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jconrel.2018.03.002","article-title":"Insights into maleimide-thiol conjugation chemistry: conditions for efficient surface functionalization of nanoparticles for receptor targeting","volume":"282","author":"Mart\u00ednez-Jothar","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2025.115057_bib51","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1016\/S0968-0896(99)00219-9","article-title":"3-(1\u2019,1\u2019-Dimethylbutyl)-1-deoxy-\u03948-THC and related compounds: synthesis of selective ligands for the CB2 receptor","volume":"7","author":"Huffman","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.colsurfb.2025.115057_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2021.702675","article-title":"Pharmacological properties, therapeutic potential and molecular mechanisms of JWH133, a CB2 receptor-selective agonist","volume":"12","author":"Hashiesh","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.colsurfb.2025.115057_bib53","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1080\/17425247.2019.1690452","article-title":"In vivo biodistribution of venlafaxine-PLGA nanoparticles for brain delivery: plain vs. Functionalized nanoparticles","volume":"16","author":"Cayero-Otero","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.colsurfb.2025.115057_bib54","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1073\/pnas.1322356111","article-title":"Differential uptake of nanoparticles by endothelial cells through polyelectrolytes with affinity for caveolae","volume":"111","author":"Voigt","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.colsurfb.2025.115057_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.mimet.2021.106260","article-title":"Refinement of the Griess method for measuring nitrite in biological samples","volume":"187","author":"Vargas-Maya","year":"2021","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.colsurfb.2025.115057_bib56","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.colsurfb.2025.115057_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep12931","article-title":"Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosis","volume":"5","author":"Schierwagen","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.colsurfb.2025.115057_bib58","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.nut.2016.12.005","article-title":"Rice bran enzymatic extract reduces atherosclerotic plaque development and steatosis in high-fat fed ApoE\u2212\/\u2212 mice","volume":"37","author":"Perez-Ternero","year":"2017","journal-title":"Nutrition"},{"key":"10.1016\/j.colsurfb.2025.115057_bib59","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/263846","article-title":"Treatment with CB2 agonist JWH-133 reduces histological features associated with erectile dysfunction in hypercholesterolemic mice","volume":"2013","author":"Fraga-Silva","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.colsurfb.2025.115057_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114471","article-title":"Cell adhesion molecule-mediated therapeutic strategies in atherosclerosis: from a biological basis and molecular mechanism to drug delivery nanosystems","volume":"186","author":"Yin","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.colsurfb.2025.115057_bib61","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2016.06.116","article-title":"Determination of the activity of maleimide-functionalized phospholipids during preparation of liposomes","volume":"514","author":"Oswald","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2025.115057_bib62","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2020.01.025","article-title":"Click chemistry in proteomic investigations","volume":"180","author":"Parker","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.colsurfb.2025.115057_bib63","article-title":"Perlecan-targeted nanoparticles for drug delivery to triple-negative breast cancer","volume":"1","author":"Khanna","year":"2019","journal-title":"Futur. Drug Discov."},{"key":"10.1016\/j.colsurfb.2025.115057_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e30601","article-title":"Stability and biological response of PEGylated gold nanoparticles","volume":"10","author":"Nguyenova","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.colsurfb.2025.115057_bib65","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.1007\/s00216-017-0527-z","article-title":"Zeta potential: a case study of cationic, anionic, and neutral liposomes","volume":"409","author":"Smith","year":"2017","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.colsurfb.2025.115057_bib66","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2023236118","article-title":"Longitudinal shear stress response in human endothelial cells to atheroprone and atheroprotective conditions","volume":"118","author":"Maurya","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.colsurfb.2025.115057_bib67","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/jat.3470","article-title":"The use of human umbilical vein endothelial cells (HUVECs) as an in vitro model to assess the toxicity of nanoparticles to endothelium: a review","volume":"37","author":"Cao","year":"2017","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.colsurfb.2025.115057_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.587012","article-title":"Nanoparticle surface functionalization: how to improve biocompatibility and cellular internalization","volume":"7","author":"Sanit\u00e0","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.colsurfb.2025.115057_bib69","article-title":"Peptide-functionalized lipid nanoparticles for targeted systemic mRNA delivery to the brain","author":"Han","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.colsurfb.2025.115057_bib70","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00066.2008","article-title":"Role of NF-\u03baB and PI 3-kinase\/Akt in TNF-\u03b1-induced cytotoxicity in microvascular endothelial cells","volume":"295","author":"Zhou","year":"2008","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.colsurfb.2025.115057_bib71","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1161\/01.ATV.0000143933.20616.1b","article-title":"Inhibition of tumor necrosis factor-\u03b1 reduces atherosclerosis in apolipoprotein e knockout mice","volume":"24","author":"Br\u00e5n\u00e9n","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.colsurfb.2025.115057_bib72","article-title":"Nile red staining for nanoplastic quantification: overcoming the challenge of false positive counts due to fluorescent aggregates","volume":"13","author":"Chatterjee","year":"2023","journal-title":"Environ. Chall."},{"key":"10.1016\/j.colsurfb.2025.115057_bib73","first-page":"109","article-title":"Endothelial-cell-based","author":"Pober","year":"2002","journal-title":"Model Inflamm. Biochem. TNF Signal. Endothel. Cells"},{"key":"10.1016\/j.colsurfb.2025.115057_bib74","article-title":"Anti-inflammatory activity of a cb2 selective cannabinoid receptor agonist: signaling and cytokines release in blood mononuclear cells","volume":"27","author":"Capozzi","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.colsurfb.2025.115057_bib75","first-page":"1","article-title":"\u03b2-Caryophyllene ameliorates MSU-Induced gouty arthritis and inflammation through inhibiting NLRP3 and NF-\u03baB signal pathway: in silico and in vivo","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.colsurfb.2025.115057_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108453","article-title":"Dietary nitrate attenuated endothelial dysfunction and atherosclerosis in apolipoprotein e knockout mice fed a high-fat diet: a critical role for NADPH oxidase","volume":"689","author":"Peng","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.colsurfb.2025.115057_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2020.104077","article-title":"A cannabinoid type 2 (CB2) receptor agonist augments NOS-dependent responses of cerebral arterioles during type 1 diabetes","volume":"133","author":"Van Hove","year":"2021","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.colsurfb.2025.115057_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25031683","article-title":"CB2 cannabinoid receptor as a potential target in myocardial infarction: exploration of molecular pathogenesis and therapeutic strategies","volume":"25","author":"More","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2025.115057_bib79","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/FJC.0b013e3181d2644d","article-title":"Activation of cannabinoid CB2 receptor ameliorates atherosclerosis associated with suppression of adhesion molecules","volume":"55","author":"Zhao","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.colsurfb.2025.115057_bib80","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.colsurfb.2025.115057_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0192824","article-title":"Systemic and vascular inflammation in an in-vitro model of central obesity","volume":"13","author":"Ahluwalia","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.colsurfb.2025.115057_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28134991","article-title":"The Anti-Inflammatory effects of cannabis sativa extracts on LPS-Induced cytokines release in human macrophages","author":"Zaiachuk","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.colsurfb.2025.115057_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28134991","article-title":"The Anti-Inflammatory effects of cannabis sativa extracts on LPS-Induced cytokines release in human macrophages","volume":"28","author":"Zaiachuk","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.colsurfb.2025.115057_bib84","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1161\/ATVBAHA.120.315255","article-title":"Local M-CSF (Macrophage Colony-Stimulating Factor) expression regulates macrophage proliferation and apoptosis in atherosclerosis","volume":"41","author":"Sinha","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.colsurfb.2025.115057_bib85","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.lfs.2014.11.027","article-title":"CB2 receptor-mediated effects of pro-inflammatory macrophages influence survival of cardiomyocytes","volume":"138","author":"Heinemann","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.colsurfb.2025.115057_bib86","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1016\/j.apsb.2023.05.019","article-title":"Engineering cannabidiol synergistic carbon monoxide nanocomplexes to enhance cancer therapy via excessive autophagy","volume":"13","author":"Xiao","year":"2023","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.colsurfb.2025.115057_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.155035","article-title":"Multifunctional Chi-Ag@HMPB@CBD nanocomposites for eradicating multidrug-resistant bacteria and promoting diabetic damaged tissue repair","volume":"498","author":"Yin","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.colsurfb.2025.115057_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1382995","article-title":"Re-evaluation of the cardioprotective effects of cannabinoids against ischemia-reperfusion injury according to the IMproving preclinical assessment of cardioprotective therapies (IMPACT) criteria","volume":"15","author":"P\u0119dzi\u0144ska-Betiuk","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.colsurfb.2025.115057_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e35138","article-title":"Cardioprotective effect of CB1 receptor antagonist AM251 against \u03b2 receptor-stimulated myocardial infarction via modulation of NF-kB signaling pathway in diabetic mice","volume":"10","author":"Pawar","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.colsurfb.2025.115057_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914494","article-title":"PPAR\u03b3 in atherosclerotic endothelial dysfunction: regulatory compounds and PTMs","volume":"24","author":"Luan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2025.115057_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells10030586","article-title":"The endocannabinoid system and ppars: focus on their signalling crosstalk, action and transcriptional regulation","volume":"10","author":"Iannotti","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.colsurfb.2025.115057_bib92","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006775","article-title":"Attenuated superoxide dismutase 2 activity induces atherosclerotic plaque instability during aging in hyperlipidemic mice","volume":"6","author":"Vendrov","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.colsurfb.2025.115057_bib93","article-title":"Blockade of CB1 or activation of CB2 cannabinoid receptors is differentially efficacious in the treatment of the early pathological events in Streptozotocin-Induced diabetic rats","volume":"24","author":"Spyridakos","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2025.115057_bib94","doi-asserted-by":"crossref","DOI":"10.1186\/s10020-021-00351-x","article-title":"CB2-mediated attenuation of nucleus pulposus degeneration via the amelioration of inflammation and oxidative stress in vivo and in vitro","volume":"27","author":"Cheng","year":"2021","journal-title":"Mol. Med."},{"key":"10.1016\/j.colsurfb.2025.115057_bib95","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jff.2016.08.037","article-title":"Atherosclerosis-related inflammation and oxidative stress are improved by rice bran enzymatic extract","volume":"26","author":"Perez-Ternero","year":"2016","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.colsurfb.2025.115057_bib96","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.atherosclerosis.2016.04.023","article-title":"Diet supplementation with rice bran enzymatic extract restores endothelial impairment and wall remodelling of ApoE-\/- mice microvessels","volume":"250","author":"Perez-Ternero","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.colsurfb.2025.115057_bib97","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jnutbio.2017.06.011","article-title":"Ferulic acid, a bioactive component of rice bran, improves oxidative stress and mitochondrial biogenesis and dynamics in mice and in human mononuclear cells","volume":"48","author":"Perez-Ternero","year":"2017","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.colsurfb.2025.115057_bib98","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/978-3-030-83395-4_14","article-title":"Factors affecting the clearance and biodistribution of polymeric nanoparticles","volume":"5","author":"Parmar","year":"2022","journal-title":"Pharmacokinet. Pharmacodyn. Nanoparticulate Drug Deliv. Syst."},{"key":"10.1016\/j.colsurfb.2025.115057_bib99","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.tips.2022.05.001","article-title":"Nanomedicine: controlling nanoparticle clearance for translational success","volume":"43","author":"Zhu","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.colsurfb.2025.115057_bib100","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1039\/D4MA00075G","article-title":"From antigen uptake to immune modulation: the multifaceted potential of peptide nanofibers as vaccine nanocarriers","volume":"5","author":"Hassan","year":"2024","journal-title":"Mater. Adv."},{"key":"10.1016\/j.colsurfb.2025.115057_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2022.152317","article-title":"Nanoparticle-induced immune response: health risk versus treatment opportunity?","volume":"228","author":"Pondman","year":"2023","journal-title":"Immunobiology"},{"key":"10.1016\/j.colsurfb.2025.115057_bib102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms24032008","article-title":"Nanomaterials and their impact on the immune system","volume":"24","author":"Aljabali","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2025.115057_bib103","doi-asserted-by":"crossref","first-page":"36092","DOI":"10.1021\/acsomega.2c03974","article-title":"Functionalized Peptide-Based nanoparticles for targeted cancer nanotherapeutics: a State-of-the-Art review","volume":"7","author":"Sharma","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.colsurfb.2025.115057_bib104","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1039\/D3EN00812F","article-title":"Clearance of nanoparticles from blood: effects of hydrodynamic size and surface coatings","volume":"11","author":"Lu","year":"2023","journal-title":"Environ. Sci. Nano."},{"key":"10.1016\/j.colsurfb.2025.115057_bib105","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.tips.2022.06.009","article-title":"Mouse models of atherosclerosis in translational research","volume":"43","author":"Ilyas","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.colsurfb.2025.115057_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2023.117275","article-title":"Sex differences in diagnostic modalities of atherosclerosis in the macrocirculation","volume":"384","author":"Kerkhof","year":"2023","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.colsurfb.2025.115057_bib107","unstructured":"A.B. Bansal, M. CassagnolHMG-CoA Reductase Inhibitors, StatPearls. (2023). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK542212\/ (accessed July 29, 2025).."},{"key":"10.1016\/j.colsurfb.2025.115057_bib108","article-title":"Regulation of PCSK9 expression and function: mechanisms and therapeutic implications","volume":"8","author":"Chen","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.colsurfb.2025.115057_bib109","article-title":"Molecular and cellular mechanisms of inflammation in atherosclerosis","volume":"10","author":"Von Hundelshausen","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.colsurfb.2025.115057_bib110","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2018.00177","article-title":"Targeting inflammation with nanosized drug delivery platforms in cardiovascular diseases: immune cell modulation in atherosclerosis","volume":"6","author":"Cervadoro","year":"2018","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.colsurfb.2025.115057_bib111","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1016\/j.apsb.2022.11.014","article-title":"Biomimetic nanomedicines for precise atherosclerosis theranostics","volume":"13","author":"Tao","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.colsurfb.2025.115057_bib112","doi-asserted-by":"crossref","first-page":"166","DOI":"10.34172\/apb.2020.022","article-title":"Cyclodextrin based nanoparticles for drug delivery and theranostics","volume":"10","author":"Gadade","year":"2020","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.colsurfb.2025.115057_bib113","doi-asserted-by":"crossref","unstructured":"Y. Li, J. Wang, J. XieBiomimetic nanoparticles targeting atherosclerosis for diagnosis and therapy, (2023). https:\/\/doi.org\/10.1002\/SMMD.20230015.","DOI":"10.1002\/SMMD.20230015"},{"key":"10.1016\/j.colsurfb.2025.115057_bib114","doi-asserted-by":"crossref","first-page":"10045","DOI":"10.2147\/IJN.S479270","article-title":"Strategies for Non-Covalent attachment of antibodies to PEGylated nanoparticles for targeted drug delivery","volume":"19","author":"Ho","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2025.115057_bib115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nano10071353","article-title":"Endothelial cell targeting by crgd-functionalized polymeric nanoparticles under static and flow conditions","volume":"10","author":"Mart\u00ednez-Jothar","year":"2020","journal-title":"Nanomaterials"}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776525005648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776525005648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:38:12Z","timestamp":1772822292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776525005648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":115,"alternative-id":["S0927776525005648"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2025.115057","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabinoid effective targeting of atherosclerotic plaques in vivo by optimized-PLGA nanoparticles","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2025.115057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115057"}}